In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
December 11th, 2008 | 26 | No |
Popular Name: (E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide (E)-N-Hydroxy-3-(4-(((2-(2-methy…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 404950-80-7 , [404950-80-7]
(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE
(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide
2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-
2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
404950-80-7; D10319; Panobinostat (USAN/INN)
D10019; Panobinostat lactate (JAN)
Panobinostat, NVP-LBH589, LBH589
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.19 | 6.33 | -22.79 | 4 | 5 | 0 | 77 | 349.434 | 7 | ↓ |
Ref Reference (pH 7) | 3.37 | 5.51 | -52.21 | 5 | 5 | 1 | 85 | 350.442 | 7 | ↓ |
Hi High (pH 8-9.5) | 3.19 | 7.58 | -62.39 | 3 | 5 | -1 | 80 | 348.426 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.19 | 7.75 | -66.77 | 5 | 5 | 1 | 82 | 350.442 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.37 | 4.15 | -8.88 | 4 | 5 | 0 | 81 | 349.434 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 95% | Fluorochem |
Target | HDAC | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HDA10-1-E | Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 31 | 0.40 | Binding ≤ 10μM |
HDA11-1-E | Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4 | 0.45 | Binding ≤ 10μM |
HDAC1-2-E | Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 7 | 0.44 | Binding ≤ 10μM |
HDAC2-1-E | Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2 | 0.47 | Binding ≤ 10μM |
HDAC3-1-E | Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.47 | Binding ≤ 10μM |
HDAC4-1-E | Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 550 | 0.34 | Binding ≤ 10μM |
HDAC5-1-E | Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 80 | 0.38 | Binding ≤ 10μM |
HDAC6-1-E | Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.47 | Binding ≤ 10μM |
HDAC7-1-E | Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4550 | 0.29 | Binding ≤ 10μM |
HDAC8-1-E | Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 22 | 0.41 | Binding ≤ 10μM |
HDAC9-1-E | Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3200 | 0.30 | Binding ≤ 10μM |
Q9XYC7-1-E | Histone Deacetylase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.47 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 21 | 0.41 | Functional ≤ 10μM |
Z80390-3-O | PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other | Other | 24 | 0.41 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 48 | 0.39 | Functional ≤ 10μM |
Z81034-6-O | A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other | Other | 35 | 0.40 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q9XYC7_PLAFA | Q9XYC7 | Histone Deacetylase, Plafa | 1.8 | 0.47 | Binding ≤ 1μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 1 | 0.48 | Binding ≤ 1μM |
HDA10_HUMAN | Q969S8 | Histone Deacetylase 10, Human | 31 | 0.40 | Binding ≤ 1μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 3.5 | 0.46 | Binding ≤ 1μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 0.65 | 0.49 | Binding ≤ 1μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 1.1 | 0.48 | Binding ≤ 1μM |
HDAC4_HUMAN | P56524 | Histone Deacetylase 4, Human | 0.6 | 0.50 | Binding ≤ 1μM |
HDAC5_HUMAN | Q9UQL6 | Histone Deacetylase 5, Human | 0.7 | 0.49 | Binding ≤ 1μM |
HDAC6_HUMAN | Q9UBN7 | Histone Deacetylase 6, Human | 0.7 | 0.49 | Binding ≤ 1μM |
HDAC7_HUMAN | Q8WUI4 | Histone Deacetylase 7, Human | 2.3 | 0.47 | Binding ≤ 1μM |
HDAC8_HUMAN | Q9BY41 | Histone Deacetylase 8, Human | 105 | 0.38 | Binding ≤ 1μM |
HDAC9_HUMAN | Q9UKV0 | Histone Deacetylase 9, Human | 1.2 | 0.48 | Binding ≤ 1μM |
Q9XYC7_PLAFA | Q9XYC7 | Histone Deacetylase, Plafa | 1.8 | 0.47 | Binding ≤ 10μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 1 | 0.48 | Binding ≤ 10μM |
HDA10_HUMAN | Q969S8 | Histone Deacetylase 10, Human | 31 | 0.40 | Binding ≤ 10μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 3.5 | 0.46 | Binding ≤ 10μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 0.65 | 0.49 | Binding ≤ 10μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 1.1 | 0.48 | Binding ≤ 10μM |
HDAC4_HUMAN | P56524 | Histone Deacetylase 4, Human | 0.6 | 0.50 | Binding ≤ 10μM |
HDAC5_HUMAN | Q9UQL6 | Histone Deacetylase 5, Human | 0.7 | 0.49 | Binding ≤ 10μM |
HDAC6_HUMAN | Q9UBN7 | Histone Deacetylase 6, Human | 0.7 | 0.49 | Binding ≤ 10μM |
HDAC7_HUMAN | Q8WUI4 | Histone Deacetylase 7, Human | 2.3 | 0.47 | Binding ≤ 10μM |
HDAC8_HUMAN | Q9BY41 | Histone Deacetylase 8, Human | 105 | 0.38 | Binding ≤ 10μM |
HDAC9_HUMAN | Q9UKV0 | Histone Deacetylase 9, Human | 1.2 | 0.48 | Binding ≤ 10μM |
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 35 | 0.40 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 48 | 0.39 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 24 | 0.41 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 21 | 0.41 | Functional ≤ 10μM |
Description | Species |
---|---|
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Circadian Clock | |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | |
Factors involved in megakaryocyte development and platelet production | |
formation of the beta-catenin:TCF transactivating complex | |
G0 and Early G1 | |
HDACs deacetylate histones | |
HSF1 activation | |
NoRC negatively regulates rRNA expression | |
NOTCH1 Intracellular Domain Regulates Transcription | |
p75NTR negatively regulates cell cycle via SC1 | |
PPARA activates gene expression | |
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alp | |
repression of WNT target genes | |
REV-ERBA represses gene expression | |
RNA Polymerase I Transcription Initiation | |
RORA activates circadian gene expression | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Transcriptional activation of mitochondrial biogenesis | |
Transcriptional regulation of white adipocyte differentiation |